Cantitate/Preț
Produs

Patient Management with Stable Ischemic Heart Disease, An Issue of Medical Clinics of North America: The Clinics: Internal Medicine, cartea 108-3

Editat de Alexander Fanaroff, John W. Hirshfeld Jr
en Limba Engleză Hardback – apr 2024
In this issue of Medical Clinics of North America, guest editors Drs. Alexander Fanaroff and John W. Hirschfeld, Jr., bring their considerable expertise to the topic of Patient Management with Stable Ischemic Heart Disease. Top experts provide insights into newer diagnostic modalities for patients presenting with symptoms of stable ischemic heart disease, review the pillars of medical management as well as emerging cardiometabolic therapies, provide updates on the role of revascularization, and reveal gender, racial, ethnic, and socioeconomic disparities in the presentation and management of stable ischemic heart disease.
Citește tot Restrânge

Din seria The Clinics: Internal Medicine

Preț: 44289 lei

Preț vechi: 56130 lei
-21% Nou

Puncte Express: 664

Preț estimativ în valută:
8476 8804$ 7041£

Carte tipărită la comandă

Livrare economică 27 ianuarie-10 februarie 25

Preluare comenzi: 021 569.72.76

Specificații

ISBN-13: 9780443293689
ISBN-10: 0443293686
Pagini: 240
Dimensiuni: 152 x 229 x 16 mm
Greutate: 0.48 kg
Editura: Elsevier
Seria The Clinics: Internal Medicine


Cuprins

The Pathophysiologic Basis of Managing Chronic Atherosclerotic Cardiovascular Disease
Diagnosing Coronary Artery Disease in the Patient Presenting with Stable Ischemic Heart Disease: The Role of Anatomic versus Functional Testing
Optimal Medical Therapy for Stable Ischemic Heart Disease in 2024: Focus on Blood Pressure and Lipids
Optimal Medical Therapy for Stable Ischemic Heart Disease: Focus on Anti-anginal Therapy
A New Age for Secondary Prevention: Optimal Medical Therapy for Stable Ischemic Heart Disease Among Patients with Diabetes and/or Obesity
Optimal Medical Therapy for Chronic Coronary Disease in 2024: Focus on Antithrombotic Therapy
Optimal Medical Therapy for Stable Ischemic Heart Disease in 2024: Focus on Exercise and Cardiac Rehabilitation
When to Consider Coronary Revascularization for Stable Coronary Artery Disease
Antiplatelet Therapy for Patients Who Have Undergone Revascularization Within the Past Year: Which Agents and for How Long?
Medical Decision-Making and Revascularization in Ischemic Cardiomyopathy
Ischemic Heart Disease in Women
Chronic Coronary Disease in Older Adults
Racial and Ethnic Disparities in the Management of Chronic Coronary Disease